1976
A. K. Prasad et al. / Bioorg. Med. Chem. 7 (1999) 1973±1977
1
118.89 (C-3 and C-5), 129.11 (C-1), 130.32(C-6), 149.86
(C-2), 153.29 (C-4), 168.26 and 168.93 (2ÂCOCH3) and
203.13 (CO); EIMS, m/z (% rel. int.): 320 [M+] (10),
278 (15), 263 (85), 236 (5), 234 (10), 221 (95), 178 (85),
137 (100), 108 (10), 81 (15), 69 (8) and 57 (25).
nM: 320 and 325; +NaOAc: 323 and 345; H NMR
(CDCl3): d 0.95 (6H, d, J=6.7 Hz, CH(CH3)2) 2.20 (1H,
m, CH), 2.34 (3H, s, OCOCH3), 2.70 (2H, d, J=6.9 Hz,
COCH2), 6.50 (1H, d, J=2.4 Hz, C-3H), 6.66 (1H, dd,
J=8.7 and 2.4 Hz, C-5H) and 7.67 (1H, d, J=8.7 Hz, C-
6H); 13C NMR (CDCl3): d 21.21 and 22.62 (2ÂCH3 and
OCOCH3), 25.29 (CH), 49.68 (COCH2), 111.20 and
113.28 (C-3 and C-5), 122.70 (C-1), 132.32 (C-6), 150.98
(C-2), 160.93 (C-4), 170.57 (COCH3) and 199.38 (CO);
EIMS, m/z (% rel. int.): 236 [M+] (17), 194 (25), 179 (26),
152 (21), 137 (100), 108 (3), 81 (5) and 43 (12).
2-Acetoxy-4-hydroxyphenly undecyl ketone (11).
Obtained as a light yellow solid, mp 104ꢀC; Rf 0.5 (sol-
vent A); IR (nujol) cm 1: 3320, 2960, 1740, 1685, 1615,
1510, 1320, 1250, 1230, 1150, 1115, 1020, 955 and 910;
UV (MeOH) nM: 313 and 326;+NaOAc: 322 and 353;
1H NMR (CDCl3): d 0.87 (3H, t, J=7.6 Hz, CH3), 1.25
(16H, s, (CH2)8), 1.64 (2H, m, CO-CH2-CH2), 2.35 (3H,
s, OCOCH3), 2.81 (2H, t, J=7.6 Hz, COCH2), 6.48 (1H,
d, J=1.9 Hz, C-3H), 6.64 (1H, dd, J=8.0 and 1.9 Hz,
C-5H) and 7.70 (1H, d, J=8.0 Hz, C-6H), 13C NMR
2-Acetoxy-4-hydroxyphenyl (1-ethyl)pentyl ketone (15).
Obtained as a viscous oil; Rf 0.4 (solvent A); [a]d23
6.6ꢀ (c 0.66, CHCl3); IR (nujol) cm 1: 3350, 3000,
1780, 1740, 1670, 1610, 1510, 1320, 1250, 1150, 1110,
1010, 900 and 820; UV (MeOH) nM: 259 and 296;
(CDCl3):
d 14.08 (CH3), 21.22 (CH3CH2) 22.65
1
(OCOCH3), 24.44, 24.95, 26.04, 28.90, 29.23, 29.59 and
31.87 (8ÂCH2), 40.78 (COCH2), 111.17 and 113.24 (C-3
and C-5), 122.49 (C-1), 132.24 (C-6), 151.02 (C-2),
160.74 (C-4), 170.44 (COCH3) and 199.27 (CO); EIMS,
m/z (% rel. int.): 334 [M+] (6), 316 (7), 292 (8), 274 (30),
194 (20), 165 (25), 152 (78), 137 (100), 123 (5) and 43 (13).
+NaOAc: 323 and 337; H NMR (CDCl3): d 0.83 (6H,
m, 2ÂCH3), 1.25 (4H, m, C-30H and C-40H), 1.50 (2H,
m, C-20H), 1.70 (2H, m, C-100H), 2.34 (3H, s, OCOCH3),
3.17 (1H, m, C-10H), 6.47 (1H, d, J=2.4 Hz, C-3H),
6.65 (1H, dd, J=8.7 and 2.4 Hz, C-5H) and 7.65 (1H, d,
J=8.7 Hz, C-6H); 13C NMR (CDCl3): d 11.70 and
13.80 (C-50 and C-200), 21.75, 22.75 and 25.11 (OCOCH3,
C-30 and C-40), 31.39 and 32.01 (C-20 and C-100), 49.45
(C-10), 107.81 and 113.21 (C-3 and C-5), 123.07 (C-1),
131.89 (C-6), 150.93 (C-2), 160.79 (C-4), 170.72
(COCH3) and 203.79 (CO); EIMS, m/z (% rel. int.): 279
[M++1] (25), 278 [M+] (6), 264 (5), 237 (85), 234 (10),
222 (95), 180 (98), 138 (95), 137 (100), 109 (30), 97 (45),
81 (65), 71 (70), 57 (90) and 43 (8).
2-Acetoxy-4-hydroxyphenyl pentadecyl ketone (12).
Obtained as a white solid, mp 105ꢀC; Rf 0.5 (solvent
A); IR (nujol) cm 1: 3330, 2960, 1740, 1690, 1250, 1230,
1115 and 960; UV (MeOH) nM: 296; +NaOAc: 323
1
and 332; H NMR (CDCl3): d 0.87 (3H, t, J=7.6 Hz,
CH3), 1.26 (24H, s, (CH2)12), 1.63 (2H, m, CO CH2
CH2), 2.35 (3H, s, OCOCH3), 2.81 (2H, t, J=7.6 Hz,
COCH2), 6.49 (1H, d, J=2.4 Hz, C-3H), 6.70 (1H, dd,
J=8.6 and 2.4 Hz, C-5H) and 7.72 (1H, d, J=8.6 Hz,
C-6H); 13C NMR (CDCl3): d 14.09 (CH3), 21.22 (CH3-
CH2), 22.68(OCOCH3), 24.42, 24.68, 29.22, 29.34,
29.42, 29.44, 29.58, 29.67, 31.91 and 33.95 (12ÂCH2),
40.82 (COCH2), 111.18 and 113.20 (C-3 and C-5),
122.67 (C-1), 132.22 (C-6), 151.06 (C-2), 160.57 (C-4),
170.27 (COCH3) and 199.06 (CO); EIMS, m/z (% rel.
int.): 392 (1), 390 [M+] (missing), 279 (4), 256 (100), 227
(10), 214 (12), 213 (34), 199 (10), 185 (22), 171 (15), 157
(20), 149 (18), 129 (45), 115 (20), 97 (22), 85 (27), 73 (80),
60 (65), 57 (63), 43 (55) and 41 (37).
Acknowledgements
We sincerely acknowledge the support and encourage-
ment extended by Professor V. S. Parmar during the
course of this research work. A.Z. and S.T. thank the
Council of Scienti®c and Industrial Research (CSIR,
New Delhi, India) for ®nancial support.
References
2-Acetoxy-4-hydroxyphenyl isopropyl ketone (13).
Obtained as a semi solid; Rf 0.4 (solvent B); IR (nujol)
cm 1: 3400, 3000, 1750, 1680, 1615, 1585, 1525, 1320,
1220, 1125, 1110, 980, 960 and 810; UV (MeOH) nM:
323 and 334; +NaOAc: 323 and 346; 1H NMR
(CDCl3): d 1.15 (6H, d, J=6.9 Hz, CH(CH3)2) 234 (3H,
s, OCOCH3), 3.37 (1H, m, CH(CH3)2) 6.50 (1H, d,
J=2.4 Hz, C-3H), 6.67 (1H, dd, J=8.7 and 2.4 Hz, C-
5H) and 7.67 (1H, d, J=8.7 Hz, C-6H); 13C NMR
(CDCl3): d 18.97 (2ÂCH3), 21.17 (OCOCH3), 37.29
(CH), 111.37 and 113.28 (C-3 and C-5), 121.82 (C-1),
131.96 (C-6), 151.22 (C-2), 160.66 (C-4), 170.63 (COCH3)
and 203.71 (CO); EIMS, m/z (% rel. int.): 222 [M+] (5),
180 (17), 179 (20), 137 (100), 81 (8), 69 (5) and 43 (7).
1. Kyogoku, K.; Hatayama, K.; Yokomori, S.; Saziki, R.;
Nakane, S.; Sasajima, M.; Sawada, J.; Ohzeki, M.; Tanake, T.
Chem. Pharm. Bull. 1979, 27, 2947.
2. Parmar, V. S.; Jain, R.; Sharma, S. K.; Vardhan, A.; Jha,
A.; Taneja, P.; Singh, S.; Vyncke, B. M.; Bracke, M. E.; Mar-
eel, M. M. J. Pharm. Sci. 1994, 83, 1217.
3. Parmar, V. S.; Bracke, M. E.; Phillippe, J.; Wengel, J.; Jain,
S. C.; Olsen, C. E.; Bisht, K. S.; Sharma, N. K.; Courtens, A.;
Sharma, S. K.; Vennekens, K.; Marck, V. V.; Singh, S. K.;
Kumar, N.; Kumar, A.; Malhotra, S.; Kumar, R.; Rajwanshi,
V. K.; Jain, R.; Mareel, M. M. Bioorg. Med. Chem. 1997, 5,
1609.
4. Parmar, V. S.; Bisht, K. S.; Jain, R.; Singh, S.; Sharma, S.
K.; Gupta, S.; Malhotra, S.; Tyagi, O. D.; Vardhan, A.; Pati,
H. N.; Berghe, D. V.; Vlietinck, A. J. Indian J. Chem. 1996,
35B, 220.
2-Acetoxy-4-hydroxyphenyl isobutyl ketone (14).
1
5. McClure, J. W. In The Flavonoids: 1st ed. Harborne, J. B.;
Mabry, H., Eds.; Chapman and Hall: London, 1975; pp 1011.
6. Sangwan, N. K.; Verma, B. S.; Malik, O. P.; Dhindsa, K. S.
Indian J. Chem. 1990, 29B, 294.
Obtained as an oil; Rf 0.4 (solvent B); IR (®lm) cm
:
3400, 3000, 1780, 1740, 1620, 1515, 1320, 1300, 1250,
1160, 1110, 1010, 970, 890, 850 and 810; UV (MeOH)